BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15289387)

  • 1. Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study.
    Gherli T; Colli A; Fragnito C; Nicolini F; Borrello B; Saccani S; D'Amico R; Beghi C
    Circulation; 2004 Aug; 110(5):496-500. PubMed ID: 15289387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation After Biological Aortic Valve Replacement: Is There An Optimal Regimen?
    Owais T; Rouman M; Breuer M; Hüter L; Fuchs J; Lauer B; Kuntze T
    J Heart Valve Dis; 2016 Mar; 25(2):139-144. PubMed ID: 27989055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral microembolization after bioprosthetic aortic valve replacement: comparison of warfarin plus aspirin versus aspirin only.
    Al-Atassi T; Lam K; Forgie M; Boodhwani M; Rubens F; Hendry P; Masters R; Goldstein W; Bedard P; Mesana T; Ruel M
    Circulation; 2012 Sep; 126(11 Suppl 1):S239-44. PubMed ID: 22965989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial.
    Rafiq S; Steinbrüchel DA; Lilleør NB; Møller CH; Lund JT; Thiis JJ; Køber L; Olsen PS
    Thromb Res; 2017 Feb; 150():104-110. PubMed ID: 27914653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing warfarin to aspirin (WoA) after aortic valve replacement with the St. Jude Medical Epic heart valve bioprosthesis: results of the WoA Epic pilot trial.
    Colli A; Mestres CA; Castella M; Gherli T
    J Heart Valve Dis; 2007 Nov; 16(6):667-71. PubMed ID: 18095518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.
    Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED;
    J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation is unnecessary after biological aortic valve replacement.
    Moinuddeen K; Quin J; Shaw R; Dewar M; Tellides G; Kopf G; Elefteriades J
    Circulation; 1998 Nov; 98(19 Suppl):II95-8; discussion II98-9. PubMed ID: 9852888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?
    ElBardissi AW; DiBardino DJ; Chen FY; Yamashita MH; Cohn LH
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1137-45. PubMed ID: 20303508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Antithrombotic Strategies in Chinese Patients in Sinus Rhythm after Bioprosthetic Mitral Valve Replacement: Early Outcomes from a Multicenter Registry in China.
    Zhang H; Dong Y; Ao X; Fu B; Dong L;
    Cardiovasc Drugs Ther; 2021 Feb; 35(1):1-10. PubMed ID: 32940891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Antithrombotic Medication Use After Bioprosthetic Aortic Valve Replacement and Outcomes in the Veterans Health Administration System.
    Bravata DM; Coffing JM; Kansagara D; Myers J; Murphy L; Homoya BJ; Perkins AJ; Snow K; Quin JA; Zhang Y; Myers LJ
    JAMA Surg; 2019 Feb; 154(2):e184679. PubMed ID: 30586138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses: A Meta-Analysis.
    Riaz H; Alansari SA; Khan MS; Riaz T; Raza S; Luni FK; Khan AR; Riaz IB; Krasuski RA
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):294-302. PubMed ID: 27166205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Guideline-Discordant Aspirin Use and Associated Adverse Events in Patients on Warfarin for Mechanical Valve Replacement.
    Haymart B; Kong X; Ali M; Schaefer JK; Froehlich JB; Ryan N; Stallings B; Barnes GD; Kaatz S
    Am J Med; 2024 May; 137(5):449-453. PubMed ID: 38280559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement?
    Sundt TM; Zehr KJ; Dearani JA; Daly RC; Mullany CJ; McGregor CG; Puga FJ; Orszulak TA; Schaff HV
    J Thorac Cardiovasc Surg; 2005 May; 129(5):1024-31. PubMed ID: 15867776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement.
    Blair KL; Hatton AC; White WD; Smith LR; Lowe JE; Wolfe WG; Young WG; Oldham HN; Douglas JM; Glower DD
    Circulation; 1994 Nov; 90(5 Pt 2):II214-9. PubMed ID: 7955256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High risk of thromboemboli early after bioprosthetic cardiac valve replacement.
    Heras M; Chesebro JH; Fuster V; Penny WJ; Grill DE; Bailey KR; Danielson GK; Orszulak TA; Pluth JR; Puga FJ
    J Am Coll Cardiol; 1995 Apr; 25(5):1111-9. PubMed ID: 7897124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonusefulness of Antithrombotic Therapy After Surgical Bioprosthetic Aortic Valve Replacement.
    Gryaznov AA; Saeyeldin A; Abdelbaky M; Zafar MA; Tanweer M; Papanikolaou D; Imran M; Li Y; Ziganshin BA; Elefteriades JA
    Am J Cardiol; 2020 Aug; 129():71-78. PubMed ID: 32605717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of aspirin use in the incidence of thromboembolic events after bioprosthesis replacement in patients with rheumatic disease.
    Durães AR; Durães MA; Correia LC; Fernandes AM; Aras Junior R
    Rev Bras Cir Cardiovasc; 2013; 28(3):347-52. PubMed ID: 24343684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic strategy after bioprosthetic aortic valve replacement in patients in sinus rhythm: evaluation of guideline implementation.
    van der Wall SJ; Umans VA; Schotten J; Keijzers M; Wolterbeek R; Jansen EK; Huisman MV; Vonk AB
    Eur J Cardiothorac Surg; 2016 Apr; 49(4):1157-63. PubMed ID: 26233944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is early antithrombotic therapy necessary after tissue mitral valve replacement?
    Colli A; D'Amico R; Mestres CA; Pomar JL; Cámara ML; Ruyra X; Mulet J
    J Heart Valve Dis; 2010 Jul; 19(4):405-11. PubMed ID: 20845885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.